GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Gross-Profit-to-Asset %

AP Biosciences (ROCO:6945) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. AP Biosciences's annualized Gross Profit for the quarter that ended in Dec. 2024 was NT$0.00 Mil. AP Biosciences's average Total Assets over the quarter that ended in Dec. 2024 was NT$1,808.42 Mil. Therefore, AP Biosciences's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 0.00%.

AP Biosciences Gross-Profit-to-Asset % Historical Data

The historical data trend for AP Biosciences's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Gross-Profit-to-Asset % Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
21.17 2.41 - 3.24 -

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial - - 6.48 - -

Competitive Comparison of AP Biosciences's Gross-Profit-to-Asset %

For the Biotechnology subindustry, AP Biosciences's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AP Biosciences's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AP Biosciences's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where AP Biosciences's Gross-Profit-to-Asset % falls into.


;
;

AP Biosciences Gross-Profit-to-Asset % Calculation

AP Biosciences's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=0/( (890.756+1727.138)/ 2 )
=0/1308.947
=0.00 %

AP Biosciences's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (1889.711+1727.138)/ 2 )
=0/1808.4245
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

AP Biosciences Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
TPE:6794 ROCO:1777 ROCO:3176 ROCO:6808 TPE:6838 ROCO:6986 ROCO:8279 ROCO:06891 ROCO:6733 ROCO:6864 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
Website
https://www.apbioinc.com
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines